SEC EDGAR · company profile · free

BRISTOL MYERS SQUIBB CO due diligence

Who BRISTOL MYERS SQUIBB CO (BMY) is on the public record: identity, industry classification and the most recent periodic filings, straight from SEC EDGAR.

1013 filings in EDGAR's recent index, 621 of them Form 4 insider filings · view the filings on SEC EDGAR · source: SEC EDGAR submissions index
CIK
0000014272
Industry (SIC)
Pharmaceutical Preparations (2834)
Incorporated
DE
Listed on
NYSE, NYSE
Tickers
BMY, CELG-RI
Fiscal year end
12-31
FilingFiledPeriodAccession
Annual report (10-K)2026-02-112025-12-310000014272-26-000004
Quarterly report (10-Q)2026-07-302026-06-300000014272-26-000020
Current report (8-K)2026-07-302026-07-300000014272-26-000018

The full due-diligence dossier on BRISTOL MYERS SQUIBB CO

The free view above is identity and filing dates. The paid dossier reads the filings: business and segments, financial trend, insider and institutional activity, litigation and risk-factor themes, recent news, and the red flags, every claim cited and delivered with a data appendix.

agents: POST /v1/dossier with {"ticker":"BMY"} over x402 or MPP, $9

Sample output and API docs · all reports

BMY insider filingsAll company profiles13F fund holdingsAll reports

Generated from public SEC EDGAR filings. Filing data is shown as filed. This is information, not investment advice.